{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T23:22:28Z","timestamp":1762298548386},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T00:00:00Z","timestamp":1480636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T00:00:00Z","timestamp":1480636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>There is relatively little literature on adjuvant radiotherapy after radical nephroureterectomy with bladder cuff excision (RNU) for patients with upper tract urothelial carcinoma (UTUC). This study was designed to determine the efficacy of adjuvant radiotherapy for patients with pT3N0M0 UTUC. We retrospectively reviewed 198 patients treated with RNU between December 2001 and January 2015. Postoperative radiotherapy was administered in 40 (20.2%) of patients. Patients who received radiotherapy were younger than those that did not (65.2 vs. 70.5 years, <jats:italic>p<\/jats:italic>\u2009=\u20090.023). With median follow up of 29.1 months, Kaplan-Meier analysis with the log-rank test demonstrated no significant differences between those omitting vs receiving adjuvant radiotherapy in regards to 2-year rates of overall survival (72.0% vs. 73.4%, <jats:italic>p<\/jats:italic>\u2009=\u20090.979), cancer-specific survival (73.2% vs. 75.3%, <jats:italic>p<\/jats:italic>\u2009=\u20090.844), and recurrence-free survival (61.2% vs. 66.3%, <jats:italic>p<\/jats:italic>\u2009=\u20090.742). However, in multivariable analysis with Cox regression, young age, absence of chronic kidney disease, negative lymphovascular invasion, negative surgical margin, and adjuvant chemotherapy were also associated with better cancer-specific survival. In conclusion, adjuvant radiotherapy did not offer any significant benefit in terms of overall, cancer-specific, and recurrence-free survivals in patients with pT3N0M0 UTUC after RNU. More effective systemic adjuvant chemotherapy is necessary to improve the outcome of these patients.<\/jats:p>","DOI":"10.1038\/srep38175","type":"journal-article","created":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T10:11:41Z","timestamp":1480673501000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Adjuvant radiotherapy for locally advanced upper tract urothelial carcinoma"],"prefix":"10.1038","volume":"6","author":[{"given":"Yun-Ching","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Hsu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo-Hsiung","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan W.","family":"Shindel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Hsuan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,12,2]]},"reference":[{"key":"BFsrep38175_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel, R., Ma, J., Zou, Z. & Jemal, A. Cancer statistics, 2014. CA Cancer J Clin 64, 9\u201329, doi: 10.3322\/caac.21208 (2014).","journal-title":"CA Cancer J Clin"},{"key":"BFsrep38175_CR2","unstructured":"Health Promotion Administration, Ministry of Health and Welfare, Taiwan. Cancer registry annual report, 2013, Taiwan. http:\/\/www.hpa.gov.tw\/Bhpnet\/Web\/Stat\/StatisticsShow.aspx?No=201604210001."},{"key":"BFsrep38175_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1464\u2013410X.2008.07565.x","volume":"102","author":"LB Tan","year":"2008","unstructured":"Tan, L. B., Chen, K. T. & Guo, H. R. Clinical and epidemiological features of patients with genitourinary tract tumour in a blackfoot disease endemic area of Taiwan. BJU Int 102, 48\u201354, doi: 10.1111\/j.1464\u2013410X.2008.07565.x (2008).","journal-title":"BJU Int"},{"key":"BFsrep38175_CR4","doi-asserted-by":"publisher","first-page":"8241","DOI":"10.1073\/pnas.1119920109","volume":"109","author":"CH Chen","year":"2012","unstructured":"Chen, C. H. et al. Aristolochic acid-associated urothelial cancer in Taiwan. Proc Natl Acad Sci USA 109, 8241\u20138246, doi: 10.1073\/pnas.1119920109 (2012).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep38175_CR5","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.jhazmat.2012.08.056","volume":"262","author":"YH Wang","year":"2013","unstructured":"Wang, Y. H. et al. Comparing the joint effect of arsenic exposure, cigarette smoking and risk genotypes of vascular endothelial growth factor on upper urinary tract urothelial carcinoma and bladder cancer. J Hazard Mater 262, 1139\u20131146, doi: 10.1016\/j.jhazmat.2012.08.056 (2013).","journal-title":"J Hazard Mater"},{"key":"BFsrep38175_CR6","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/cncr.24135","volume":"115","author":"V Margulis","year":"2009","unstructured":"Margulis, V. et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer 115, 1224\u20131233, doi: 10.1002\/cncr.24135 (2009).","journal-title":"Cancer"},{"key":"BFsrep38175_CR7","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.eururo.2015.06.044","volume":"68","author":"M Roupret","year":"2015","unstructured":"Roupret, M. et al. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update. Eur Urol 68, 868\u2013879, doi: 10.1016\/j.eururo.2015.06.044 (2015).","journal-title":"Eur Urol"},{"key":"BFsrep38175_CR8","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.eururo.2008.01.054","volume":"54","author":"CC Li","year":"2008","unstructured":"Li, C. C. et al. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients. Eur Urol 54, 1127\u20131134, doi: 10.1016\/j.eururo.2008.01.054 (2008).","journal-title":"Eur Urol"},{"key":"BFsrep38175_CR9","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.juro.2007.03.115","volume":"178","author":"CF Wu","year":"2007","unstructured":"Wu, C. F. et al. The impact factors on prognosis of patients with pT3 upper urinary tract transitional cell carcinoma. J Urol 178, 446\u2013450, dicussion 450, doi: 10.1016\/j.juro.2007.03.115 (2007).","journal-title":"J Urol"},{"key":"BFsrep38175_CR10","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/S0022-5347(05)67019-X","volume":"164","author":"JJ Munoz","year":"2000","unstructured":"Munoz, J. J. & Ellison, L. M. Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol 164, 1523\u20131525 (2000).","journal-title":"J Urol"},{"key":"BFsrep38175_CR11","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.juro.2015.03.077","volume":"194","author":"YC Huang","year":"2015","unstructured":"Huang, Y. C. et al. The Efficacy of Postoperative Adjuvant Chemotherapy for Patients with pT3N0M0 Upper Tract Urothelial Carcinoma. J Urol 194, 323\u2013329, doi: 10.1016\/j.juro.2015.03.077 (2015).","journal-title":"J Urol"},{"key":"BFsrep38175_CR12","unstructured":"Roupr\u00eat, M. et al. Upper Urinary Tract Urothelial carcinoma. (Date of access: 20\/10\/2016). European Association of Urology web sitehttp:\/\/uroweb.org\/guideline\/upper-urinary-tract-urothelial-cell-carcinoma\/(2016)."},{"key":"BFsrep38175_CR13","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.hoc.2014.10.003","volume":"29","author":"I Lucca","year":"2015","unstructured":"Lucca, I., Leow, J. J., Shariat, S. F. & Chang, S. L. Diagnosis and management of upper tract urothelial carcinoma. Hematol Oncol Clin North Am 29, 271\u2013288, ix, doi: 10.1016\/j.hoc.2014.10.003 (2015).","journal-title":"Hematol Oncol Clin North Am"},{"key":"BFsrep38175_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0022-5347(01)66563-7","volume":"155","author":"C Maulard-Durdux","year":"1996","unstructured":"Maulard-Durdux, C. et al. Postoperative radiation therapy in 26 patients with invasive transitional cell carcinoma of the upper urinary tract: no impact on survival? J Urol 155, 115\u2013117 (1996).","journal-title":"J Urol"},{"key":"BFsrep38175_CR15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S1078-1439(96)00095-6","volume":"2","author":"CN Catton","year":"1996","unstructured":"Catton, C. N. et al. Transitional cell carcinoma of the renal pelvis and ureter: Outcome and patterns of relapse in patients treated with postoperative radiation. Urol Oncol 2, 171\u2013176 (1996).","journal-title":"Urol Oncol"},{"key":"BFsrep38175_CR16","first-page":"333","volume":"34","author":"E Jwa","year":"2014","unstructured":"Jwa, E. et al. Adjuvant radiotherapy for stage III\/IV urothelial carcinoma of the upper tract. Anticancer Res 34, 333\u2013338 (2014).","journal-title":"Anticancer Res"},{"key":"BFsrep38175_CR17","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/1471\u20132407\u201311\u2013297","volume":"11","author":"B Chen","year":"2011","unstructured":"Chen, B. et al. Radiotherapy may improve overall survival of patients with T3\/T4 transitional cell carcinoma of the renal pelvis or ureter and delay bladder tumour relapse. BMC Cancer 11, 297, doi: 10.1186\/1471\u20132407\u201311\u2013297 (2011).","journal-title":"BMC Cancer"},{"key":"BFsrep38175_CR18","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000343729","volume":"90","author":"NY Jang","year":"2013","unstructured":"Jang, N. Y., Kim, I. A., Byun, S. S., Lee, S. E. & Kim, J. S. Patterns of failure and prognostic factors for locoregional recurrence after radical surgery in upper urinary tract transitional cell carcinoma: implications for adjuvant radiotherapy. Urol Int 90, 202\u2013206, doi: 10.1159\/000343729 (2013).","journal-title":"Urol Int"},{"key":"BFsrep38175_CR19","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S0022-5347(01)62763-0","volume":"160","author":"MC Hall","year":"1998","unstructured":"Hall, M. C., Womack, J. S., Roehrborn, C. G., Carmody, T. & Sagalowsky, A. I. Advanced transitional cell carcinoma of the upper urinary tract: patterns of failure, survival and impact of postoperative adjuvant radiotherapy. J Urol 160, 703\u2013706 (1998).","journal-title":"J Urol"},{"key":"BFsrep38175_CR20","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1097\/01.ju.0000137910.38441.8a","volume":"172","author":"B Czito","year":"2004","unstructured":"Czito, B., Zietman, A., Kaufman, D., Skowronski, U. & Shipley, W. Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter. J Urol 172, 1271\u20131275 (2004).","journal-title":"J Urol"},{"key":"BFsrep38175_CR21","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/(SICI)1097-0142(19990315)85:6<1342::AID-CNCR17>3.0.CO;2-B","volume":"85","author":"YH Chou","year":"1999","unstructured":"Chou, Y. H. & Huang, C. H. Unusual clinical presentation of upper urothelial carcinoma in Taiwan. Cancer 85, 1342\u20131344 (1999).","journal-title":"Cancer"},{"key":"BFsrep38175_CR22","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.eururo.2009.12.032","volume":"57","author":"WM Li","year":"2010","unstructured":"Li, W. M. et al. Oncologic outcomes following three different approaches to the distal ureter and bladder cuff in nephroureterectomy for primary upper urinary tract urothelial carcinoma. Eur Urol 57, 963\u2013969, doi: 10.1016\/j.eururo.2009.12.032 (2010).","journal-title":"Eur Urol"},{"key":"BFsrep38175_CR23","doi-asserted-by":"publisher","first-page":"149750","DOI":"10.1155\/2014\/149750","volume":"2014","author":"SM Wang","year":"2014","unstructured":"Wang, S. M. et al. Increased upper and lower tract urothelial carcinoma in patients with end-stage renal disease: a nationwide cohort study in Taiwan during 1997\u20132008. Biomed Res Int 2014, 149750, doi: 10.1155\/2014\/149750 (2014).","journal-title":"Biomed Res Int"},{"key":"BFsrep38175_CR24","doi-asserted-by":"publisher","first-page":"e1164","DOI":"10.1097\/MD.0000000000001164","volume":"94","author":"CS Lin","year":"2015","unstructured":"Lin, C. S. et al. Hemodialysis Is Associated With Increased Peripheral Artery Occlusive Disease Risk Among Patients With End-Stage Renal Disease: A Nationwide Population-Based Cohort Study. Medicine (Baltimore) 94, e1164, doi: 10.1097\/MD.0000000000001164 (2015).","journal-title":"Medicine (Baltimore)"},{"key":"BFsrep38175_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1749-8546-3-13","volume":"3","author":"SC Hsieh","year":"2008","unstructured":"Hsieh, S. C., Lin, I. H., Tseng, W. L., Lee, C. H. & Wang, J. D. Prescription profile of potentially aristolochic acid containing Chinese herbal products: an analysis of National Health Insurance data in Taiwan between 1997 and 2003. Chin Med 3, 13, doi: 10.1186\/1749-8546-3-13 (2008).","journal-title":"Chin Med"},{"key":"BFsrep38175_CR26","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","volume":"31","author":"JD Cox","year":"1995","unstructured":"Cox, J. D., Stetz, J. & Pajak, T. F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31, 1341\u20131346, doi: 10.1016\/0360-3016(95)00060-C (1995).","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFsrep38175_CR27","first-page":"461","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey, A. S. et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Annals of internal medicine 130, 461\u2013470 (1999).","journal-title":"Modification of Diet in Renal Disease Study Group. Annals of internal medicine"},{"key":"BFsrep38175_CR28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0140\u20136736(11)60178-5","volume":"379","author":"AS Levey","year":"2012","unstructured":"Levey, A. S. & Coresh, J. Chronic kidney disease. Lancet 379, 165\u2013180, doi: 10.1016\/S0140\u20136736(11)60178-5 (2012).","journal-title":"Lancet"},{"key":"BFsrep38175_CR29","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S0360-3016(03)00124-X","volume":"56","author":"WC Chen","year":"2003","unstructured":"Chen, W. C. et al. Concurrent cisplatin, 5-fluorouracil, leucovorin, and radiotherapy for invasive bladder cancer. International journal of radiation oncology, biology, physics 56, 726\u2013733 (2003).","journal-title":"International journal of radiation oncology, biology, physics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep38175.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep38175","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep38175.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:42:33Z","timestamp":1672879353000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep38175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,2]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,23]]}},"alternative-id":["BFsrep38175"],"URL":"https:\/\/doi.org\/10.1038\/srep38175","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,2]]},"assertion":[{"value":"4 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38175"}}